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Differing Lectin Binding Profiles among Human
Embryonic Stem Cells and Derivatives Aid in the Isolation
of Neural Progenitor Cells
Mahesh C. Dodla1, Amber Young1, Alison Venable2, Kowser Hasneen1, Raj R. Rao3, David W. Machacek4,
Steven L. Stice1,4*
1 Regenerative Bioscience Center, University of Georgia, Athens, Georgia, United States of America, 2 Department of Biochemistry and Molecular Biology, University of
Georgia, Athens, Georgia, United States of America, 3 Department of Chemical and Life Sciences Engineering, Virginia Commonwealth University, Richmond, Virginia,
United States of America, 4 ArunA Biomedical Inc., Athens, Georgia, United States of America

Abstract
Human embryonic stem cells (hESCs) and their differentiated progeny allow for investigation of important changes/events
during normal embryonic development. Currently most of the research is focused on proteinacous changes occurring as a
result of differentiation of stem cells and little is known about changes in cell surface glycosylation patterns. Identification of
cell lineage specific glycans can help in understanding their role in maintenance, proliferation and differentiation.
Furthermore, these glycans can serve as markers for isolation of homogenous populations of cells. Using a panel of eight
biotinylated lectins, the glycan expression of hESCs, hESCs-derived human neural progenitors (hNP) cells, and hESCs-derived
mesenchymal progenitor (hMP) cells was investigated. Our goal was to identify glycans that are unique for hNP cells and
use the corresponding lectins for cell isolation. Flow cytometry and immunocytochemistry were used to determine
expression and localization of glycans, respectively, in each cell type. These results show that the glycan expression changes
upon differentiation of hESCs and is different for neural and mesenchymal lineage. For example, binding of PHA-L lectin is
low in hESCs (1464.4%) but significantly higher in differentiated hNP cells (9960.4%) and hMP cells (9063%). Three lectins:
VVA, DBA and LTL have low binding in hESCs and hMP cells, but significantly higher binding in hNP cells. Finally, VVA lectin
binding was used to isolate hNP cells from a mixed population of hESCs, hNP cells and hMP cells. This is the first report that
compares glycan expression across these human stem cell lineages and identifies significant differences. Also, this is the first
study that uses VVA lectin for isolation for human neural progenitor cells.
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Little progress has been made towards defining the carbohydrate surface of hESCs and their differentiated progeny despite
recent findings of the importance in cell surface glycoproteins for
maintenance of pluripotency, self-renewal, and differentiation. For
example, Notch has been implicated in not only directing neural
stem cells to a glial cell fate but also neural stem cell renewal.
While these two findings may seem contradictory, glysosylation of
Notch on different serine residues could cause different outcomes
[7–8]. Thus, the complexity of the carbohydrate surface has an
important role in cell differentiation and renewal. There are
several other examples: the role of heparan sulphate proteoglycans
in hedgehog signaling [9], chondroitin sulphate proteoglycans in
neural migration and differentiation [10–13] and recent interest in
Galectin-1, a carbohydrate binding protein expressed on mouse
neural precursor cells that may affect proliferation of neural stem
cells [14–15]. The role of the carbohydrate surface is now being
brought to the forefront.

Introduction
Human embryonic stem cells (hESCs) can be differentiated into
neural progenitor (hNP) cells [1] and mesenchymal progenitor
(hMP) cells [2] in vitro. hESC-derived hNP cells and hMP cells
provide an invaluable source of cells to study early human neural
and mesodermal development, respectively, as well as cell
replacement therapy, drug screening, and toxicological studies.
Human NP cells are likely to follow a similar differentiation
pathway as in vivo neurogenesis, based on murine studies where
early expression of neural markers upon differentiation in vitro can
parallel that of mouse neurogenesis [3–4]. Similarly, hMP cells are
likely to follow similar differentiation pathway as adult bone
marrow derived mesenchymal stem cells [2,5–6]. The differentiation process allows for investigation of the developmental stages
and the associated changes that occur on the cell surface as either
a result of or possibly a cause in early differentiation.
PLoS ONE | www.plosone.org
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progenitor (hMP) cells, as described previously [1–2]. Here, to
study lectin binding, hESCs were cultured on BD matrigelTM
(BD Biosciences) coated 100-mm tissue culture dishes (Techno
Plastic Products, Switzerland) and mTeSRH1 medium (Stem Cell
Technologies Inc., Vancouver, Canada), according to the
company’s instructions. The mTeSRH1 culture medium was
changed every day and the cells passaged every 4–5 days when
the colonies became large and began to merge with each other.
For passaging, the culture medium was removed, cells were
rinsed with PBS22 (without calcium and magnesium, Gibco
Invitrogen) once, and 2 ml of dispase enzyme (1 mg/ml, Stem
Cell Technologies Inc.) was added for 7 minutes. Dispase solution
was then removed and the cells were rinsed with 4 ml of
mTeSRH1 medium once. Fresh mTeSRH1 medium was added
again and the colonies were scraped off using a cell scraper
(Techno Plastic Products, Switzerland). The cells were passaged
1:3 or 1:4 depending on density. The mTeSRH1 medium was
changed after two days and then every other day, until ready for
passaging again.
The derivation protocols for adherent cultures of hNP cells and
hMP cells from hESCs are not discussed here and can be reviewed
in previous works [1–2]. hNP cells were cultured on BD
MatrigelTM coated 100-mm tissue culture treated dishes. Cells
were cultured in proliferation medium composed of AB2TM
medium (ArunA Biomedical Inc., Athens, GA) supplemented with
ANSTM (ArunA Biomedical Inc.), 20 ng/ml Leukimia Inhibitory
Factor (LIF, Millipore), 2 mM L- Glutamine, 0.5 U/ml penicillin,
0.5 U/ml streptomycin (all from Gibco Invitrogen), 20 ng/ml
FGF-2 (Sigma). Culture medium was changed every other day and
hNP cells were passaged every 3–4 days using either a cell scraper
or manual pipetting. hNP cells between passage numbers 20–30
were used for this study.
Human mesenchymal progenitor (hMP) cells were cultured in
mesenchymal medium consisting of alpha-DMEM, 10% defined
fetal bovine serum (FBS, Hyclone), 1 mM L- Glutamine,
0.5 U/ml penicillin, and 0.5 U/ml streptomycin (all from Gibco
Invitrogen unless otherwise stated). The culture medium was
changed every other day and cells passaged every 3–4 days. For
passaging cells from a T-175 flask, 5 ml of 0.05% trypsin, at 37uC,
was added and cells incubated at 37uC for 4–5 minutes. To stop
the reaction, 2 ml of mesenchymal medium was added. The cells
were further dissociated by pipetting 8–10 times with a 10 ml
serological pipette. The cell suspension was centrifuged at 1000
RPM for 4 minutes to pellet the cells. The cells were re-suspended
in fresh medium and passaged at 1:2 or 1:3 dilutions. For this
study, hMP cells between passages 7–12 were used.

Previous studies have characterized the carbohydrate surface of
hESCs [16–17] and their differentiated progeny in embryoid body
differentiation [18–19]. However, embryoid body differentiation
gives rise to cells of multiple lineages which makes it difficult to
characterize each lineage separately. In our laboratory, we have
derived highly enriched adherent cultures of human neural
progenitor (hNP) cells [1] and human mesenchymal progenitor
(hMP) cells [2] by directed differentiation of WA09 hESCs. To
ensure a homogeneous population, hESCs, hNP cells and hMP
cells were first characterized with pluripotent, neural and
mesenchymal intracellular and extracellular markers, previously
[1–2], and again during this study. The homogenous populations
make them ideal for characterization of the cells’ carbohydrate
expression. A panel of eight lectins was selected based on previous
studies [16–17] to probe the carbohydrate expression on the cell
surface of hESCs, hNP cells and hMP cells. Lectins are
carbohydrate binding proteins that recognize diverse sugar
structures. We characterized percentages and localization of cellslectin binding by flow cytometry and immunocytochemistry,
respectively. The binding specificity of each lectin was validated
using appropriate competitive sugars.
Here, for the first time glycan expression across multiple
identified cell types has been compared demonstrating several
significant and novel patterns. For example, in hNP cells- lectin
binding is enhanced, compared to that of the hESCs and hMP
cells, suggesting that increased glycosylation occurs upon neural
differentiation in vitro; whereas in hMP cells, lectin binding was
similar or reduced as compared to that of hESCs. Upon hESCs
differentiation to hNP cells and hMP cells, PHA-L lectin binding
increases, indicating an up-regulation in expression of complex Ntype glycans containing b1–6 linked branches. We also identify
that expression of N-acetyl-D-galactosamine (VVA lectin), Nacetyl-D-glucosamine (DBA lectin) and Fuca1,3-GlcNAc glycans
(LTL lectin) is significantly up regulated in hNP cells, compared to
hESCs and hMP cells. Using the VVA lectin, which binds to Nacetyl-D-galactosamine, we isolated hNP cells from a mixed
population of hESCs, hNP cells and hMP cells. This study
identifies several extracellular carbohydrate antigens that could be
exploited to further characterize and define the hNP cell
phenotype.

Materials and Methods
Cell culture and passaging
NIH registered hESC line WA09 was used for derivation of
differentiated neural progenitor (hNP) cells and mesenchymal
Table 1. Features of reviewed plant lectins.

Lectin Name

Abbreviation

Oligosaccharide Specificity

Inhibitor

Concanavalin A

Con A

N-linked High Mannose or Hybrid,
N-linked Di-antennary

200 mM a-methylmannoside ora-methyl
glucoside

Phaseolus vulgarisleucoagglutinin

PHA-L

N-linked Tri andTetra-antennary
withGalb(1,4)GlNAcb(1,6)Man

200 mM galactose

Maackia amurensis agglutinin

MAA

galactosyl (b-1,4)N-acetylglucosamine

200 mM lactose

Vicia villosa agglutinin

VVA

a- or b-linked terminalN-acetylgalactosamine

200 mM N-acetylgalactosamine

Dolichos biflorusagglutinin

DBA

(b-1,4) linkedN-acetylglucosamine oligomers

200 mM N-acetylgalactosamine

Phaseolus vulgariserythroagglutinin

PHA-E

N-linked bisected structures

200 mM galactose

Lotus tetragonolobuslectin

LTL

Fuca1,3-GlcNAc

50–100 mM L-fucose

Arachis hypogeaAgglutinin/peanut

PNA

galactosyl (b-1,3)N-acetylgalactosamine

200 mM galactose

doi:10.1371/journal.pone.0023266.t001
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Figure 1. Defining the stem cell phenotype using immunocytochemistry and flow cytometry. Phase contrast image of hESCs (A), hNPs
(B), and hMPs (C). hESCs express pluripotency markers: Oct 4 (D,GG, JJ), SSEA-4 (G), and Sox 2 (J,GG); lack expression of Nestin (M, JJ), CD 166 (P,DD),
CD73 (DD), and CD105 (AA). hNPs have low expression of pluripotency markers: Oct 4 (E,KK), SSEA-4 (H); and mesenchymal markers CD 166 (Q,EE),
CD73 (EE), and CD105 (BB). hNPs express neural markers: Sox 2 (J,HH) and Nestin (N,HH,KK). hMPs lack expression of pluripotency markers: Oct 4
(F,LL), SSEA-4 (I), and Sox 2 (L,II); however, hMPs express Nestin (O,II,LL), CD 166 (R,FF), CD73 (FF), CD90 (CC) and CD105 (CC). All the cells have been
stained with the nuclear marker DAPI (blue) in panels D- P. Scale bar: 10 mm. In the dot plots, red dots indicate isotype control or secondary antibody
only; black dots indicate the antigen staining.
doi:10.1371/journal.pone.0023266.g001

PBS22 and then stained with secondary antibody or isotype
control. The secondary antibodies were purchased from
Molecular Probes and used at 1:1000 dilution: donkey antimouse APC, mouse anti-goat 488, donkey anti-rabbit PE, and
goat anti-rabbit APC. The isotype controls were purchased from
BD pharmingen and used 1:1000 dilution: mouse IgG APC, rat
IgM PE, and mouse IgG FITC. Cells stained with secondary
antibody only or isotype controls were used as controls. Flow
cytometry was performed using CyAn cytometer (Beckman
Coulter, Brea, CA) using two lasers – tuned to 488 nm and
633 nm. Data analysis was performed using FlowJo (Tree Star,
Inc., Ashland, Oregon). Percentage of cells expressing fluorescence intensity greater than the control cells were calculated
using FlowJo program.

Immunocytochemistry of cells for stem cell markers
Immunocytochemistry (ICC) was used to ascertain expression of
appropriate markers for the three cell types: hESC (POU5F1+/
Oct4+, SSEA-4+, SOX-2+, Nestin2 and CD1662), hNP cells
(Oct42, SSEA-42, SOX-2+, Nestin+ and CD1662) and hMP cells
(Oct42, SSEA-42, SOX-22, Nestin+ and CD166+). Four-well
chamber slides (BD Biosciences) were used for plating and
immunostaining of all the three cell types. WA09 hESCs were
passaged onto BD MatrigelTM coated 4-well chamber slides; two
days later, the cells were fixed and stained. The hNP cells were
collected from 100-mm dish by manual pipetting and plated onto
BD MatrigelTM coated 4-well dishes at 50,000 cells/well in fresh
proliferation medium. The cells were fixed and stained the next
day. hMP cells were passaged from T-175 flasks (BD Falcom)
using 0.05% trypsin and plated onto 4-well chamber slides
(without MatrigelTM) at 50,000 cells/well. The cells were fixed and
stained the next day.
All the three cell types were fixed in 2% paraformaldehyde
(Fisher Scientific) in 16 PBS++ (with calcium and magnesium,
Gibco Invitrogen) for 20 minutes. The cells were then washed
three times with PBS++ and blocked with 1% BSA in PBS++
solution for 30 minutes. Primary and secondary antibodies were
diluted in the block solution. Cells were then stained with
primary antibodies separately for each of the marker proteins:
mouse anti-Oct4 (1:500, Hybridoma), mouse anti-SSEA-4 (1:20
dilution, Hybridoma), mouse anti-SOX-2 (1:100, R&D Systems), mouse anti-Nestin (1:200, Neuromics), mouse anti-CD166
(1:100, BD Pharmingen) for 1 hr at room temperature. The cells
were washed 3 times in PBS++ and incubated with secondary
antibodies for 1 hr at room temperature. Secondary antibodies
included streptavidin conjugated Alexafluor 594 (Molecular
Probes; Eugene, OR; 1:1000 dilution) and goat anti-Mouse IgG
conjugated Alexa 488 (Molecular Probes; 1:1000 dilution). Cells
were again washed three times, 5 minutes each, in PBS++; and
post-stained with 49-6-Diamidino-2-phenylindole (DAPI, Invitrogen) to detect cell nuclei. Cells incubated with secondary
antibodies alone were used as controls. All slides were mounted
and visualized using a Nikon TS100 inverted microscope.
Individual color channels were captured separately and merged
in Adobe Photoshop software (Adobe Inc.).

Immunocytochemistry to characterize cell- lectin binding
Table 1 shows the lectins used in this study, their commonly
abbreviated name, the specificity of these lectins for their
respective oligosaccharide structures and the concentration of
hapten, or competitive sugar, that was used to verify specificity of
each lectin for its carbohydrate. Specificity of each lectin has
previously been described in detail by Cummings and colleagues
[20].
The localization of cell surface carbohydrate moieties on
routinely maintained adherent cultures of WA09 hESCs, hNP
cells and hMP cells was analyzed by immunocytochemistry.
hESCs, hNP cells and hMP cells were plated in 4-well chamber
slides as mentioned above.
All three cell types were fixed, washed and blocked as
mentioned above. Cells were then stained with one of eight
biotinylated lectins (Table 1, all lectins obtained from Vector
Laboratories; Burlingame, CA; 10 mg/ml in block solution) for
20 minutes at 37uC. The cells were also co-stained with a lineage
specific marker: hESCs with mouse anti-SSEA-4 (1:20 dilution,
Hybridoma), hNP cells with mouse anti-Nestin (1:200, Neuromics); hMP cells with mouse anti-CD166 (1:100, BD Pharmingen). The cells were washed three times in PBS++ and incubated
with secondary antibodies for 30 minutes at 37uC. Secondary
antibodies included streptavidin conjugated Alexafluor 594
(Molecular Probes; Eugene, OR; 1:1000 dilution) and goat antiMouse IgG conjugated Alexa 488 (Molecular Probes; 1:1000
dilution). Cells were again washed three times, 5 minutes each, in
PBS++; and post-stained with DAPI (Invitrogen) to detect cell
nuclei. Cells incubated with secondary antibodies alone and
without lectins or primary antibodies were used as controls. All
slides were mounted and visualized using a Nikon TS100 inverted
microscope.

Flow cytometry analysis for stem cell markers
The percentage of cells expressing lineage specific markers
was determined by flow cytometry. hESCs, hNP cells and hMP
cells were harvested as described above, collected in 15 ml
sterile conical tubes (Sarstedt Inc.), and fixed in 2% paraformaldehyde in 16 PBS22. The cells were blocked in PBS with
3% fetal bovine serum and 1% BSA for 30 minutes, and placed
in sterile conical tubes in aliquots of 500,000 cells for each
replicate per antigen. Each cell type was stained with one of the
7 antibodies for 1 hour at room temperature: Rabbit anti-Oct4
(1:200, Sigma-Aldrich), Goat anti-Sox2 (1:100, Millipore),
Mouse anti-nestin (1:100, Neuromics), CD73-APC (1:20),
CD166-PE (1:5), CD90-APC (1:100), and CD105-FITC (1:20),
all from BD Pharmingen. Cells were washed 3 times with
PLoS ONE | www.plosone.org

Flow cytometry analysis to determine percentage
cell-lectin binding
The percentage of cells expressing a particular cell surface
glycoprotein and binding to corresponding lectin was determined
by flow cytometry. hESCs, hNP cells and hMP cells were
harvested as described above, collected in 15 ml sterile conical
tubes (Sarstedt Inc.), and fixed in 2% paraformaldehyde in
4
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Figure 2. Flow cytometry histograms of lectin binding in hESCs, hNPs and hMPs. Percentage of cells binding to 8 different lectins was
determined by flow cytometry. A representative lectin histogram plot is shown for one of 4 experimental replicates. In each panel far left grey fill peak
in the histogram plot correlates with cells stained with secondary antibody only, and the shifted black tracing peak represents cells binding to a
lectin. Panels in the left column show histograms of 8 different lectins binding to hESCs. Panels in the middle column are for hNP cells and panels in
the right column are for hMP cells. Gating for each histogram indicates % of cells positive for the lectin-binding.
doi:10.1371/journal.pone.0023266.g002

16 PBS22. The cells were blocked in 1% BSA for 30 minutes,
and placed in sterile conical tubes in aliquots of 500,000 cells for
each replicate per lectin. Each cell type was stained with one of the
8 lectins (Table 1) at 5 mg/ml. Cells were washed 3 times with
PBS22 and then stained with secondary antibody, streptavidin allophycocyanin (1:250 dilution, BD Biosciences). Cells stained
with secondary antibody only were used as controls. Flow
cytometry was performed using CyAn cytometer (Beckman
Coulter, Brea, CA) using two lasers – tuned to 488 nm and
633 nm. Data analysis was performed using FlowJo (Tree Star,
Inc., Ashland, Oregon). Percentage of cells expressing fluorescence
intensity greater than the control cells were calculated using
FlowJo program. Significance was determined by a Two-way
ANOVA and Tukey’s Pair-Wise (SAS, Cary, NC, USA)
comparisons for each lectin binding for the hESCs, hNP cells
and hMP cells. Results where a P-value,0.05 were considered to
be significantly different.

types separately were also stained with fluorescein-conjugated
VVA lectin and used as controls.
From the 3 cell mixture, cells having highest expression of
fluorescein were sorted out into conical tubes and then plated onto
4-well chamber slides. Next day, the sorted cells (approximately
16 hours later) were fixed and stained, as mentioned above, for
expression of Nestin, SOX-2, Oct4, SSEA-4 and CD 166 markers.

Results
Characterization of hESCs, hNP cells and hMP cells for
stem cell markers
Cultures of hESCs were maintained on MatrigelTM coated
100-mm tissue culture dishes. hESCs were stained to ensure
positive expression for pluripotency markers and negative
expression for the lineage specific markers. Most of the hESCs
were positive for Oct4 (Figure 1D), SSEA-4 (Figure 1G) and
SOX-2 (Figure 1J). The hESCs were negative for Nestin
(Figure 1M), a neural marker, and CD 166 (Figure 1P), a
mesenchymal marker.
Human NP cells were derived from WA09 hESCs as described
previously [1]. hNP cells can be propagated on MatrigelTM
coated 100-mm tissue culture dishes for many passages (Figure 1B)
and maintain normal karyotype (tested up to 40 passages, data
not shown here). These cultures are positive for expression of
Nestin (Figure 1N) and SOX-2 (Figure 1K), two main neural
stem cell markers, and negative for expression of hESC
pluripotency markers Oct4 (Figure 1E) and SSEA-4(Figure 1H);
as well as negative for CD 166 (Figure 1Q), a mesenchymal
marker.

Fluorescence Assisted Cell Sorting based on VVAfluorescein lectin
Cell sorting was performed using MoFlo cell sorter (Beckman
Coulter, Brea, CA) with the laser tuned at 488 nm. Data analysis
was performed using FlowJo program (Tree Star,Inc., Ashland,
Oregon). The experiment was repeated three times. hESCs, hNP
cells and hMP cells were harvested as described above for flow
cytometry. The 3 cell types were mixed in 1:1:1 ratio and then
blocked in 1% BSA for 30 minutes at room temperature. The cell
mix was then stained with fluorescein-conjugated VVA lectin at
5 mg/ml for 20 minutes at 37uC. Cells were then washed twice
with PBS22 and taken for sorting. Similarly, each of the 3 cell

Figure 3. Quantification of lectin binding in hESC, hNP and hMP cell surfaces with 8 different lectins. The percent of cells with specific
carbohydrate expression was determined by flow cytometry using 8 different lectins. Each of the 3 cell types were separately stained with one of 8
lectins. The data is represented as average +/2 SD of 4 independent assays of hESCs, hNP cells and hMP cells. Means with different letters are
significantly different, # indicates p,0.05 compared to hESCs and * indicates p,0.05 compared to hNP cells.
doi:10.1371/journal.pone.0023266.g003
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Figure 4. Immunocytochemistry of hESC cultures for SSEA-4 expression and binding to lectins. The panels in the left column show
hESCs staining for SSEA-4 and DAPI (panels A, D, G, J, M, P, S, and V). In the same field of view as the left panel, the middle panels show binding of
ConA(B), Pha-L (E), MMA (H), VVA (K), DBA (N), Pha-E (Q), LTL (T), and PNA (W) lectins in hESCs. The merge view of lectin and SSEA-4 staining is shown
in panels in the right column. The staining amount roughly correlates with flow cytometry analysis. Scale bar: 10 mm.
doi:10.1371/journal.pone.0023266.g004

b-galactosyl (PNA). The remaining four lectins bound to fewer
WA09 hESCs (p,0.05), these were DBA (2964%), PHA-L
(1464.4%), LTL (861%), and VVA (160.4%) lectins. Thus,
fewer WA09 hESCs express the glycan structures: complex
N-type glycans containing b1–6 linked branches (PHA-L),
N-acetyl-D-galactosamine (VVA), a GalNac (DBA) and a(1,2)
L-fucose (LTL).
Next, we consider hNP cells- lectins binding here. Five of the
eight lectins bound to higher percentage of hNP cells than hESCs
(p,0.05), while the remaining three lectin-binding was similar
(p.0.05, Figure 3). The lectins and their binding percentages to
hNP cells are: PHA-L (9960.4%), MAA (9960.2%), ConA
(9762%), VVA (9663%), PHA-E (9663%), PNA (9361%),
LTL (7264.5%), and DBA (6365.9%). Thus, very high
percentages of hNP cells express the glycan structures: amannopyranosyl (ConA), complex N-type glycans containing
b1–6 linked branches (PHA-L), Neu5Ac residues (MAA), Nacetyl-D-galactosamine (VVA), a GalNac (DBA), complex Nglycan structures containing GlcNac (PHA-E), a(1,2)L-fucose
(LTL) and b-galactosyl (PNA).
Finally, we consider hMP cells- lectins binding here. Lectin
binding profiles for hMP cells was different compared to hNP
cells and hESCs, indicating that cell surface glycosylation
pattern is lineage specific. Comparing hMP cells to hESCs
(Figure 3), we found that lectin-cell binding percentages were
similar for 4 lectins (p.0.05): ConA, MAA, VVA and PHA-E;
and thus similar percentages of hESCs and hMP cells express
the glycans: a-mannopyranosyl (ConA), Neu5Ac residues
(MAA), N-acetyl-D-galactosamine (VVA) and complex Nglycan structures containing GlcNac (PHA-E). Percentage of
hMP cells positive for PHA-L lectin binding (thus expression of
complex N-type glycans containing b1–6 linked branches) was
significantly higher (9163%, p,0.05) than hESCs. For the rest
of the 3 lectins: DBA, LTL and PNA; percentages of cells
positive was significantly lower (p,0.05) for hMP cells
compared to hESCs.

hMP cells were derived from hESCs as described previously [2]
and cultured on tissue culture treated T-175 flasks (Figure 1C).
hMP cells were negative for expression of Oct4 (Figure 1F), SSEA4 (Figure 1I) and SOX-2 (Figure 1L); and positive for the markers
Nestin (Figure 1O) and CD 166 (Figure 1R). Cultures of hESCs
(SSEA-4+), hNP cells (Nestin+, SOX-2+) and hMP cells (CD166+)
were stained regularly to ensure that the cultures were homogenous (visual observation) before further analysis.

Flow Cytometry analysis for expression of stem cell
markers
WA09 hESC, hNP and hMP cells were immuno-stained for
pluripotent markers (co-staining for Oct4 and Sox2), co-stained
for nestin and Sox2; and for the mesenchymal lineage markers
CD166, CD105, CD73 and CD90. The cells were then analyzed
by flow cytometry. WA09 hESC have high expression of
pluripotent markers Oct4 (83%, Figure 1GG) and Sox2 (98%,
Figure 1GG), and low expression for nestin (8.1%, Figure 1JJ),
mesenchymal markers CD105 (4.8%, Figure 1AA), CD73 (2.6%,
Figure 1DD), CD166 (0.26%, Figure 1DD). Human NP cells
have low Oct4 expression (14%, Figure 1KK), and high
expression of nestin (94%, Figure 1HH, 1KK) and Sox2
(97.2%, Figure 1HH). Human NP cells have low expression for
mesenchymal markers CD105 (1.44%, Figure 1BB), CD73
(0.82%, Figure 1EE) and CD166 (0.02%, Figure 1EE). On the
other hand, hMP cells have low expression for Oct4 (4.5%,
Figure 1LL) and Sox2 (2.6%, Figure 1II); and high expression for
mesenchymal markers CD105 (56.2%, Figure 1CC), CD73
(92.7%, Figure 1FF) and CD166 (94.7%, Figure 1FF). Human
NP and MP cells both express nestin (Figure 1HH and 1II,
respectively).
The flow cytometry analysis shows that the three cell lines, H9
hESC, hNP and hMP, correctly express their lineage markers and
have minimal or no cross contamination.

Analysis of carbohydrate expression by flow cytometry
Table 1 shows a list of the lectins used in this study and the
oligosaccharides to which they bind. Binding of these lectins
represents presence of various carbohydrate structures on the cell
surface. Using flow cytometry, analysis of individual histograms
of each lectin binding shows peak shifts of lectin-stained cells
(black outline histogram, Figure 2) relative to secondary
antibody-only (grey-filled histogram, Figure 2) stained cells.
Four replicates were completed for each lectin and cell type,
experiments were repeated twice and the average values from
the 2 repetitions was calculated and analyzed. The lectin-cell
binding percentages indicate the percentages of cells positive for
lectin binding. A range of lectin binding percentages was
observed for the 3 cell types (hESCs, hNP cells and hMP cells)
indicating the presence of various glycans on cell surfaces
(Figure 3).
First, we consider the hESCs- lectin binding here. Four of the
lectins bound to a large percentage of WA09 hESCs, these were
MAA (9760.2%), PHA-E (9163.4%), PNA (9162.4%), and
ConA (7668.4%) (Figure 3). Thus, high percentages of hESCs
express a-mannopyranosyl (ConA), Neu5Ac residues (MAA),
complex N-glycan structures containing GlcNac (PHA-E), and
PLoS ONE | www.plosone.org

Carbohydrate analysis using immunocytochemistry
Human ESCs, hNP cells and hMP cells were also analyzed by
immunocytochemistry to determine localization of carbohydrates
and to determine whether particular staining patterns were
present in adherent cultures. Results for all 8 lectins supported
our flow cytometry analysis. For hESCs, the cultures were costained with the pluripotency cell surface marker SSEA-4
(Figure 4, left column). ConA (Figure 4B), MAA (Figure 4H),
PHA-E (Figure 4Q) and PNA (Figure 4W) appeared to bind
uniformly to hES cell surface, and the intensity of staining was
highest for PHA-E. The lectins PHA-L (Figure 4E), VVA
(Figure 4K), DBA (Figure 4N) and LTL (Figure 4T) bound to
only a small percentage of hESCs. The staining was punctuated
but uniform throughout.
For hNP cells, all the lectins appear to bind uniformly to hNP
cell surface, and the staining intensities appeared similar for all
the lectins (Figure 5). hNP cells were co-stained for Nestin, a
filament protein, and for the cell nuclei with DAPI, a DNA
binding dye. We did not observe localization of lectin binding
on regions on individual cells, cell clusters or cell phenotype. For
8
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Figure 5. Immunocytochemistry of hNP cell cultures for Nestin expression and binding to lectins. The panels in the left column show
hNP cells staining for Nestin and DAPI (panels A, D, G, J, M, P, S, and V). In the same field of view as the left panel, the middle panels show binding of
ConA(B), Pha-L (E), MMA (H), VVA (K), DBA (N), Pha-E (Q), LTL (T), and PNA (W) lectins in hNP cells. The merge view of lectin and Nestin staining is
shown in panels in the right column. The staining amount roughly correlates with flow cytometry analysis. Scale bar: 10 mm.
doi:10.1371/journal.pone.0023266.g005

found in mouse neural precursor cells [22], and are similar to
human CSPGs.
Previously, we have used lectins to catalog the various
glycans presented on the carbohydrate surface of pluripotent,
SSEA-4 sorted BG01 hESCs [16–17]. Wearne et al., using
similar methodology, substantiated these previous results and
discerned carbohydrate changes on BG01 hESCs allowed to
randomly differentiate into 12- and 28- day embryoid bodies
[18–19]. Various differentiated cell types were present in the
embryoid bodies as determined by lineage specific markers.
However, due to the minimal number of each differentiated cell
type per lineage, glycosylation changes accompanying differentiation was limited. Here, we present the analysis of lectin
binding and the glycan profiles of WA09 hESCs, hNP cells and
hMP cells.
First, we characterized the hESCs, hNP cells and hMP cells
with stem cell markers. Immunocytochemistry shows that WA09
hESCs are positive for embryonic stem cell markers Oct4,
SSEA-4 and SOX-2, while negative for lineage specific markers
Nestin (neural) and CD166 (mesenchymal). hNP cells were
negative for Oct4, SSEA-4 and CD166, while positive for Nestin
and SOX-2. Human NP cultures also lack expression of beta III
tubulin (TUJ1), a marker for more mature neuronal cells. Our
hNP cultures, when further differentiated into mature CNS cell
types; do express markers for neurons, oligodendrocytes, and
glial cells [1,23–24]. Nestin, a widely referenced neuronal stem
cell marker [25] was employed to stain in concert with each
lectin. Nestin expression appears to be tightly regulated and
after multipotent neural stem cells differentiate into a committed
cell fate, Nestin expression decreases [26]. Similarly, hMP cells
were negative for Oct4, SSEA-4 and SOX-2, while positive for
Nestin and CD166. hMP cells used in this study can undergo
osteogenic and chondrogenic, but not adipogenic differentiation; suggesting that hMP cells are multipotent progenitor
cells [2].
A comparison of lectin binding of the multipotent hNP cells
and hMP cells to the SSEA-4+ pluripotent hESCs enables the
identification of glycan changes accompanying differentiation.
PHA-L lectin binding, hence expression of N-type glycans
containing b1–6 linked branches, was significantly up regulated
upon hNP and hMP differentiation; suggesting that these glycan
structures are important in differentiation. Potentially, PHA-L
binding can be used to separate differentiated cell types from
pluripotent hESCs and hence for enrichment of pluripotent cells.
Using the 8 lectins mentioned in this study, we did not detect any
glycan structures that were downregulated in both hNP cells and
hMP cells, compared to hESCs. In future studies, we plan to use
a more extensive collection of lectins to identify additional glycan
structures that might be upregulated in hESCs and down
regulated upon differentiation. Lectin microarray analysis can be
used for high-throughput and sensitive analysis of a large set of
biological samples and glycans [27–28]. Toyoda et al used lectin
microarray technology to study glycan expression on undifferentiated hES cells and differentiated hES cells after embryoid
body (EB) formation [28]. Similarly, glycan expression was
compared between human induced pluripotent stem (hiPSC)
cells, the parental lung fibroblasts they were generated from, and

hMP cells, high percentages of cells bound to ConA, PHA-L,
MAA and PHA-E lectins (Figure 6B, 6E, 6H and 6Q,
respectively), similar to our observations with flow cytometry.
The lectin staining was punctuated and uniform all over the cell
surface. Intensity of staining was low for ConA and highest for
PHA-E lectin. The rest of the 4 lectins: VVA, DBA, LTL and
PNA (Figure 6K, 6N, 6T and 6W, respectively) had very low
binding with hMP cells, which corroborated with flow
cytometry data. The hMP cells were co-stained for CD166, a
mesenchymal marker, and cell nuclei with DAPI (Figure 6, left
column).

Fluorescence Assisted Cell Sorting of hNP cells using
VVA-fluorescein lectin
VVA lectin bound to high percentages of hNP cells (9663%),
and low percentages of hESCs (160.3%) and hMP cells (160.1%)
(Figure 3). Here we tested whether VVA lectin could be used to
select hNP cells from a mix population of hESCs, hNP cells and
hMP cells. The 3 cell types were harvested and mixed in 1:1:1
ratio; stained with VVA-fluorescein lectin and sorted for cells with
highest fluorescein expression. The next day (approximately
16 hours later), the sorted cells were fixed and stained for
expression of Nestin, SOX-2, Oct4, SSEA4 and CD 166 proteins.
All the sorted cells (Figure 7) were positive for expression of Nestin,
SOX-2, and negative for expression of Oct4 and CD166. These
results indicate that VVA lectin binding can be used to isolate hNP
cells from other cell types.

Discussion
Since the isolation of hESCs, many studies have looked at the
factors that cause or promote differentiation of hESCs. Most
research is centered on the proteinous elements involved in
differentiation while significantly less is being focused on the role
of carbohydrate surface. Here, we probed the carbohydrate
surface of WA09 hESCs and two of its derivative cell types,
neural progenitors and mesenchymal progenitors, using lectins. A
panel of 8 lectins was used which, although not exhaustive,
allowed us to detect differences in glycan expressions among the 3
cell types. In this study we have identifed three glycan structures
that are specifically upregulated in hNP cells as compared to
hESCs and hMP cells. Further, based on one of the glycan
structures, N-acetyl-D-galactosamine (binding to VVA lectin), we
could isolate pure populations of hNP cells from a mix of hESCs,
hNP cells and hMP cells. To our knowledge, this is the first study
where glycan expression of hESCs, hNP cells and hMP cells has
been compared to identify lineage specific expression. Also, this is
the first study where VVA lectin has been used for isolation of
hNP cells.
Transmembrane and cell surface proteins containing key
carbohydrates are thought to play critical roles in neural stem
cell biology including differentiation, migration, and cell renewal
[21], suggesting the carbohydrate surface as one important
extrinsic factor of neurogenesis. Importantly, recent research has
been reported on various chondroitin sulfate proteoglycans
(CSPGs), including aggrecan, phosphacan, and tenascin that are
PLoS ONE | www.plosone.org
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Figure 6. Immunocytochemistry of hMP cell cultures for CD 166 expression and binding to lectins. Binding of ConA(B), Pha-L (E), MMA
(H), VVA(K), DBA(N), Pha-E (Q), LTL (T), and PNA (W) lectins in hMP cells. In the same field of view, CD 166 and DAPI staining is shown in panels in the
left column. The merge view of lectin and CD 166 staining is shown in panels in the right column. The staining amount roughly correlates with flow
cytometry analysis. Scale bar: 10 mm.
doi:10.1371/journal.pone.0023266.g006

the differentiated hiPS EBs. The signals for MAL and PHA-L
lectin binding in the hES cells were lower than those in EBs,
while the signal for EEL is higher in hES cells than EBs. Hence
EEL and PHA-L can be used for positive and negative
identification, respectively, of hES cells. These findings corroborate with our results that PHA-L binding increases upon
differentiation of hES cells. Hence, PHA-L can be used for
exclusion of differentiated pluripotent stem cells. In a similar
study Tateno et al compared glycan expression among 114 types
of hiPSCs generated from five different somatic cells and
compared their glycomes with those of hESC [27]. Lectin
binding of PHA-E, PHA-L, VVAII lectins, among some others,
decreases upon induction of pluripotency in somatic cells. This
again is similar to our findings that binding of PHA-E, PHA-L
and VVA is higher in hNP and hMP cells, compared to WA09
hESC.
Upon directed differentiation of hESCs into hNP cells, the
lectins bind to higher percentage of hNP cells than hESCs
(Figure 3). Conclusions from this work suggest the presence of
many glycans on hNP surfaces. Expression of 3 glycans Neu5AC
a(2,3) Gal/GalNAc (MAA), b GlcNac (PHA-E) and terminal bGal (PNA), is similar to hESCs. However, the expression of four
glycans was significantly up regulated in hNP cells compared to
hESCs: b1–6 branched oligosaccharides (PHA-L), GalNac end
groups (VVA), a-linked N-acetylgalactosamine (DBA), and
fucose moieties a-linked to GlcNAc (LTL). hNP cells’ binding
to VVA lectin is significantly higher than hESCs and hMP cells.
Versican, a chondroitin sulphate proteoglycan and member of
the lectican family, has been shown to be a major receptor for
VVA lectin [29]. Versican induces neural differentiation and

promotes neurite outgrowth [30]. Although we cannot be
certain that VVA lectin is binding to versican, per se, we do see
an increase in binding percentage of this lectin in neural
differentiation, suggesting that GalNac end groups (VVA) might
have utility as a glycan marker for neurogenesis. Further
isolation, culture, and in vitro and in vivo differentiation of VVA+
hNP cells will determine the unique properties of this population
of neural progenitor cells. Mandai et al demonstrated that
combination of WGA and ECA lectins can be used to improve
derivation of retinal photoreceptor cells from mouse ESC [31].
WGA and ECA lectins bind to Rx-positive cells and can be used
for enrichment. The enrichment of Rx-positive cells significantly
increased the further derivation of retinal photoreceptor
precursor cells. It is possible that VVA lectins bind to a subtype
of neural cells and could be used for their enrichment.
Whether the carbohydrate signature of cell type changes as a
result of differentiation, or if glycans influence or play a more
direct role in cellular fate is a question that plagues the field.
Hence, it is critical to define the cell surface of differentiated cell
types to probe glycan functions and potentially for cell sorting. In
the present study we have identified glycan expression on
homogenous populations of hESCs, hNP cells and hMP cells,
and compared the glycan expression across the cell types. By
comparing hESCs, hNP cells and hMP cells, we have identified
glycan structures that are unique to hNP cells: GalNac end groups
(VVA), a-linked N-acetylgalactosamine (DBA), and fucose moieties a-linked to GlcNAc (LTL). Future studies help in identifying
the roles of these glycans in cell maintenance, proliferation and
differentiation fate.

Figure 7. Fluorescence assisted cell sorting of hNPs using VVA lectin. hMP cells (A), hESCs (B) and hNP cells (C) stained with VVA-fluorescein
lectin, analyzed for binding and used as controls. A mixed population of hESCs, hNPs and hMPs (1:1:1 ratio) was stained with VVA-fluorescein lectin
and sorted for fluorescein positive cells (D). The sorted cells stained positive for Nestin and SOX2 (E); and were negative for OCT4 (F), and CD166 (G).
Cells were stained with DAPI for nucleus. Scale bar: 10 mm.
doi:10.1371/journal.pone.0023266.g007
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